Extract
We read with interest the study reported by Collin et al. [1], who carried out a survey on organisation and priorities of national tuberculosis (TB) programmes in Europe. With an estimated annual incidence of 10 million cases, TB is considered one of the three global infectious disease priorities, together with HIV/AIDS and malaria. However, TB incidence has significantly declined in the general European population during the past two decades, with a relative increase in vulnerable groups [2, 3].
Abstract
The majority of patients completing anti-tuberculosis treatment have sequelae and benefit from pulmonary rehabilitation http://ow.ly/WyOH30nFQLV
Acknowledgements
This article belongs to the scientific activities of the WHO Collaborating Centre for Tuberculosis and Lung Diseases, Tradate, ITA-80, 2017-2020- GBM/RC/LDA and of the GTN (Global Tuberculosis Network) Working Group on TB and Pulmonary Rehabilitation, TB Treatment Committee (Chair: Marcela Muňoz Torrico).
Footnotes
Conflict of interest: D. Visca has nothing to disclose.
Conflict of interest: E. Zampogna has nothing to disclose.
Conflict of interest: G. Sotgiu has nothing to disclose.
Conflict of interest: R. Centis has nothing to disclose.
Conflict of interest: L. Saderi has nothing to disclose.
Conflict of interest: L. D'Ambrosio has nothing to disclose.
Conflict of interest: V. Pegoraro has nothing to disclose.
Conflict of interest: P. Pignatti has nothing to disclose.
Conflict of interest: M. Muňoz-Torrico has nothing to disclose.
Conflict of interest: G.B. Migliori has nothing to disclose.
Conflict of interest: A. Spanevello has nothing to disclose.
- Received November 16, 2018.
- Accepted January 26, 2019.
- Copyright ©ERS 2019
LIBRARY USERS
Log in through your institution
Purchase access
